HHS' healthy food agenda puts hospitals on notice about patients' meals
medicalxpress - Complaints about hospital food are certainly not new, and Jell-O and fruit juice are often the butt of related jokes. But the Trump administration has recently upped the ante.
AI Summary: The Department of Health and Human Services is tightening standards for patient meals, signaling hospitals must redesign menus, monitor nutrition policies and prepare for compliance reviews. Facilities face operational and financial pressures to meet healthier food requirements, prompting early planning across dietary services as regulators move from suggestions to enforceable expectations.
- Debate over ultra-processed foods and nutrition science (3)
- HHS healthy food rules put hospitals on notice (4)
- Hospitals struggle with food-as-medicine and cost pressures (4)
- All Other Stories
Debate over ultra-processed foods and nutrition science
HHS healthy food rules put hospitals on notice
Hospitals struggle with food-as-medicine and cost pressures
All Other Stories
Delays in visa program threaten doctor placements in underserved areas
medicalxpress - Hundreds of foreign doctors about to complete training in the U.S. will have to leave the country if the federal government doesn't rapidly process their visa waiver applications, which have been languishing since the fall and winter, immigration attorney…
AI Summary: Delays and backlogs in the physician visa program are jeopardizing placement of hundreds of doctors destined for underserved communities, leaving health systems scrambling to fill gaps. Hospitals warn patient access and care continuity could suffer as credentialing and onboarding timelines stretch, forcing local providers to shoulder heavier loads.
US may lose measles elimination status after outbreaks spread to 45 states
medicalxpress - After public health experts declared measles eliminated in the U.S. in 2000, the U.S. Centers for Disease Control and Prevention (CDC) established seven indicators of measles elimination status to ensure that the country remained on track. Now, analyzing …
AI Summary: Widespread measles outbreaks now touch dozens of states, raising alarms that the US could lose its measles elimination status. Public health teams warn of falling immunity, rising transmission, and the urgent need for vaccination campaigns, while unconventional signals—like prediction markets—are drawing attention as noisy but sometimes useful outbreak indicators.
- Detection and science: markets, sequencing, and treatments (3)
- Threat to U.S. measles elimination and spread drivers (4)
- Vaccine hesitancy, framing, safety, and delivery capacity (4)
- All Other Stories
Detection and science: markets, sequencing, and treatments
Threat to U.S. measles elimination and spread drivers
Vaccine hesitancy, framing, safety, and delivery capacity
All Other Stories
3 Dead in Hantavirus Outbreak Aboard Cruise Ship, W.H.O. Says
Alexandra E. Petri / nytimes - One case of the infection has been confirmed in a laboratory, and there are five additional suspected cases, the organization said on Sunday.
AI Summary: A suspected hantavirus outbreak on an Atlantic cruise ship has been linked to three deaths, prompting a WHO-led investigation and urgent public-health follow-up. Authorities are coordinating testing, contact tracing and onboard inspections while reminding the public that hantaviruses are typically rodent-borne and can cause severe respiratory illness if unchecked.
- Hantavirus basics and cruise outbreak risks (7)
- Stranded MV Hondius: passengers and routing (3)
- WHO probes deaths, possible human transmission (4)
- All Other Stories
Hantavirus basics and cruise outbreak risks
Stranded MV Hondius: passengers and routing
WHO probes deaths, possible human transmission
All Other Stories
Court restricts abortion access across US by blocking mailing of mifepristone
abcnews - A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking the mailing of mifepristone
AI Summary: A federal appeals court has imposed new limits on distribution of mifepristone, blocking mail-order shipments and narrowing telehealth-based prescribing. The decision immediately complicates access for patients and clinicians who rely on remote care and pharmacy delivery, forcing last‑minute logistical changes, increased travel, and swift legal and policy responses as providers scramble to adapt.
- Appeals court halts mail and telehealth access (4)
- Clinical pivots and drug alternatives amid disruptions (3)
- Supreme Court temporarily restores mail access (5)
- All Other Stories
Appeals court halts mail and telehealth access
Clinical pivots and drug alternatives amid disruptions
Supreme Court temporarily restores mail access
All Other Stories
U.S. Government Will Stop Paying for Test Strips to Detect Deadly Drugs
Jan Hoffman / nytimes - In a letter to states and other grant recipients, the Trump administration says the strips encourage drug use.
AI Summary: Public health officials have declared the South Carolina measles outbreak over after nearly 1,000 people fell ill, attributing containment to intensified vaccination campaigns and contact tracing. Authorities warn that immunity gaps still exist and stressed that preventable outbreaks will recur without sustained immunization efforts — a blunt reminder that vaccines remain the easiest way to avoid headline-making contagions.
Cigna exits ACA exchanges despite dramatic profit growth in Q1
Rebecca Pifer Parduhn / healthcaredive - The insurer plans to say goodbye to the ACA exchanges after this year, and is exploring a potential sale of its controversial claims review subsidiary. Both businesses were more trouble than they were worth, executives said.
AI Summary: Cigna announced it will withdraw from Affordable Care Act individual exchanges even after reporting robust first-quarter earnings. The insurer cites strategic and operational reasons for exiting markets where risk and costs bite, a move likely to reduce competition in some states and could leave consumers with fewer plan choices or higher premiums.
11 cancers on the rise in young people - scientists find first clue why it's happening
bbc - Researchers stress that simple lifestyle changes can still significantly reduce the risk of cancer.
AI Summary: New studies report rising incidence of several cancers among younger adults, with England data showing increases in bowel and ovarian cancers and researchers claiming early clues to underlying drivers. Scientists are calling for urgent investigation into environmental, lifestyle, and diagnostic factors, enhanced surveillance and prevention measures — because apparently youth is no longer a guarantee.
- New lab discoveries point to targeted, immune-based cancer therapies (4)
- Other health stories: infections, liver care, social impacts on youth (5)
- Prevention and screening gaps risk late diagnoses, experts warn (4)
- Younger adults facing rising cancers — investigators hunt environmental culprits (7)
- All Other Stories
New lab discoveries point to targeted, immune-based cancer therapies
Other health stories: infections, liver care, social impacts on youth
Prevention and screening gaps risk late diagnoses, experts warn
Younger adults facing rising cancers — investigators hunt environmental culprits
All Other Stories
First-Ever Smell Map Is a Breakthrough in Sensory Research, a Step to Help Us Tackle Loss of Smell
discovermagazine - Discover how smell receptors in our noses aren’t randomly arranged but are highly organized, offering new paths toward treating sensory impairment.
AI Summary: Scientists have produced the first high‑resolution olfactory map, charting how scent receptors and neural circuits are organized in the nose. The atlas exposes unexpected patterns in odor encoding, helps explain smell loss, and points to new diagnostic and therapeutic pathways — including potential early markers of Alzheimer’s‑related olfactory damage.
- Hidden nose atlas rewrites smell organization, flags Alzheimer links (4)
- New brain markers and tests for early Alzheimer detection (4)
- All Other Stories
Hidden nose atlas rewrites smell organization, flags Alzheimer links
New brain markers and tests for early Alzheimer detection
All Other Stories
Preeclampsia could be treated with 'blood filtering' therapy, early study hints
livescience - A blood-filtering therapy for preeclampsia is safe for pregnant patients and their babies, according to a new pilot study.
AI Summary: Early clinical work suggests removing a circulating anti‑angiogenic factor can safely extend pregnancies in severe preeclampsia. Researchers used targeted extracorporeal filtration to lower soluble Fms‑like tyrosine kinase‑1 (sFlt‑1) levels, improving maternal and fetal stability long enough to delay delivery and reduce immediate risks, meriting larger controlled trials.
Eugene Braunwald, Whose Research Reshaped Cardiology, Dies at 96
Jonathan Kandell / nytimes - His work changed how doctors understood heart attacks, heart failure and coronary artery disease, and helped lead to therapies that saved millions of lives.
AI Summary: Eugene Braunwald, a towering figure whose research reshaped modern cardiology, has died at 96. Colleagues remember his seminal contributions to cardiac physiology, therapeutics, and clinical practice that set the stage for decades of advances. His passing marks the end of an era for a field he helped steer.
Introducing the Chairs at ISCO Congress 2026 – Part 1
oncodaily - International School of Clinical Oncology – ISCO shared a series of posts on Facebook, introducing the Chairs at the upcoming ISCO Congress 2026: 1. “We are delighted to welcome Prof. […]
AI Summary: The ISCO Congress 2026 has unveiled its chairpersons and session lineup, spotlighting leaders shaping the program and key scientific themes. Organizers framed the event as a platform for multidisciplinary exchange and translational oncology priorities, aiming to accelerate research-to-clinic progress while giving attendees plenty to talk about between coffee breaks.
- Leadership, training and career-development programs (4)
- Major trial takeaways across 2026 oncology congresses (4)
- Meet the ISCO 2026 Chairs and Honorees (6)
- Scientific tracks: AI, translational & cellular therapy (4)
- All Other Stories
Leadership, training and career-development programs
Major trial takeaways across 2026 oncology congresses
Meet the ISCO 2026 Chairs and Honorees
Scientific tracks: AI, translational & cellular therapy
All Other Stories
Tick season off to a fast start, and some experts worry about future illnesses
abcnews - Tick season seems to be off to a fast start, with an unusually high number of bites already reported across the country
AI Summary: Tick season is starting early and with gusto: health officials are seeing an uptick in tick encounters and emergency-department visits, and experts warn that expanding tick range could drive more tick-borne illnesses in coming months. Public-health authorities urge vigilance, prompt removal, and better surveillance to avoid this season’s bite turning into a bigger problem.
WHO approves first malaria treatment for infants
medicalxpress - The World Health Organization announced Friday that it had given prequalification approval to a malaria treatment for newborns and infants for the first time.
AI Summary: The World Health Organization has cleared the first malaria treatment specifically for infants, granting prequalification that paves the way for broader procurement and use in endemic countries. Regulators' sign-off targets a vulnerable age group long underserved by effective pediatric therapies, potentially speeding distribution through global health channels and donor programs.
FTC moves to shut down health insurance fraud scheme
Jakob Emerson / beckershospitalreview - A federal court has temporarily halted a Florida-based operation that the Federal Trade Commission alleges collected more than $91 million by deceiving consumers into purchasing fake health insurance coverage. The FTC filed its complaint April 7 in the U.…
AI Summary: The Federal Trade Commission filed suit seeking to halt a telemarketing operation accused of selling bogus PPO insurance plans. The action alleges deceptive practices that harmed consumers and triggered enforcement to freeze assets and shut down the scheme, demonstrating regulators still have a pulse when fraudsters find creative ways to sell imaginary “coverage.”
FDA backs 3 psychedelic drug studies for mental illness
Ella Ruder / beckershospitalreview - The FDA is issuing national priority vouchers to three companies studying psychedelic drugs to treat serious mental illness. The vouchers were issued to companies studying psilocybin for treatment-resistant depression and major depressive disorder as well…
AI Summary: The FDA announced a targeted push to accelerate clinical research into psychedelics for mental illness, issuing three commissioner vouchers to support rigorous trials of psychedelic therapies. The move aims to fast-track evidence generation under regulatory oversight, signalling growing agency willingness to explore unconventional treatments while keeping safety and trial standards squarely in view.
- FDA voucher push and federal policy shift (5)
- Psilocybin and brain science (4)
- Real-world use, safety and clinical readiness (3)
- All Other Stories
FDA voucher push and federal policy shift
Psilocybin and brain science
Real-world use, safety and clinical readiness
All Other Stories
CMS, FDA announce new program to speed up Medicare coverage of breakthrough medical devices
fiercehealthcare - The Trump administration unveiled a new program to speed up Medicare coverage for breakthrough devices, touting that the new pathway cuts red tape for medical device companies to gain reimbursement. CMS said it will pause the existing TCET pathway.
AI Summary: CMS and the Food and Drug Administration launched a coordinated program to accelerate Medicare coverage for breakthrough medical devices, aiming to shorten the gap between regulatory approval and patient access. The initiative aligns agency review processes, defines eligibility, and seeks faster coverage decisions while maintaining safety and evidentiary standards.
- New imaging and monitoring devices promise faster, remote patient care. (3)
- On scene: agencies align to speed device approvals and coverage. (6)
New imaging and monitoring devices promise faster, remote patient care.
On scene: agencies align to speed device approvals and coverage.
Gene therapy improves hearing in 90% of patients with inherited deafness in largest trial of its kind
livescience - A new gene therapy tested in China has improved the hearing of 38 people who were born deaf due to mutations in a gene called OTOF.
AI Summary: A gene therapy for inherited deafness delivered dramatic results, restoring hearing in roughly 90% of treated patients in the largest trial of its kind. Investigators report durable improvements over follow-up, signaling a potential one-time intervention for certain genetic deafness types and challenging the notion that auditory loss is always irreversible. Hope, meet hard data.
- FDA approves first-ever gene therapy for inherited hearing loss (6)
- Primate study finds human-like genetic cause of blindness (1)
- Trial shows durable hearing restored in most patients (3)
FDA approves first-ever gene therapy for inherited hearing loss
Primate study finds human-like genetic cause of blindness
Trial shows durable hearing restored in most patients
FDA approves 1st 2-drug HIV treatment
Ella Jeffries / beckershospitalreview - The FDA has approved Merck’s once-daily, two-drug regimen for adults with virologically suppressed HIV-1. The treatment combines 100 mg doravirine and 0.25 mg islatravir and is indicated for patients with no history of virologic treatment failure and no k…
AI Summary: The FDA has approved Merck’s once‑daily two‑drug antiretroviral regimen, marking a notable market entrant poised to compete with established single‑pill therapies. Regulators cleared the novel combination on efficacy and safety data, setting up potential shifts in prescribing, pricing and competition — and giving Gilead something new to grumble about.
Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial
Kristin Jensen / healthcaredive - A program that got caught up in HHS’ decision to abandon mRNA research was revived by a public-private coalition and is now beginning a large, late-stage test that could support a future approval.
AI Summary: Moderna has initiated a clinical trial of an mRNA vaccine targeting a potentially pandemic bird‑flu strain, joining global efforts to have a rapid‑response countermeasure ready. Regulators and public‑health experts hail the move as sensible pre‑emptive science—because nothing says “we planned for this” like testing the vaccine before the outbreak arrives.